Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2007 2
2008 2
2009 1
2010 2
2011 4
2012 6
2013 2
2014 3
2015 4
2016 1
2017 3
2018 5
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductases.
Fersing C, Boudot C, Pedron J, Hutter S, Primas N, Castera-Ducros C, Bourgeade-Delmas S, Sournia-Saquet A, Moreau A, Cohen A, Stigliani JL, Pratviel G, Crozet MD, Wyllie S, Fairlamb A, Valentin A, Rathelot P, Azas N, Courtioux B, Verhaeghe P, Vanelle P. Fersing C, et al. Among authors: Rathelot P. Eur J Med Chem. 2018 Sep 5;157:115-126. doi: 10.1016/j.ejmech.2018.07.064. Epub 2018 Aug 1. Eur J Med Chem. 2018. PMID: 30092366 Free PMC article.
Nongenotoxic 3-Nitroimidazo[1,2-a]pyridines Are NTR1 Substrates That Display Potent in Vitro Antileishmanial Activity.
Fersing C, Basmaciyan L, Boudot C, Pedron J, Hutter S, Cohen A, Castera-Ducros C, Primas N, Laget M, Casanova M, Bourgeade-Delmas S, Piednoel M, Sournia-Saquet A, Belle Mbou V, Courtioux B, Boutet-Robinet É, Since M, Milne R, Wyllie S, Fairlamb AH, Valentin A, Rathelot P, Verhaeghe P, Vanelle P, Azas N. Fersing C, et al. Among authors: Rathelot P. ACS Med Chem Lett. 2018 Dec 19;10(1):34-39. doi: 10.1021/acsmedchemlett.8b00347. eCollection 2019 Jan 10. ACS Med Chem Lett. 2018. PMID: 30655943 Free PMC article.
Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series.
Kieffer C, Cohen A, Verhaeghe P, Hutter S, Castera-Ducros C, Laget M, Remusat V, M'Rabet MK, Rault S, Rathelot P, Azas N, Vanelle P. Kieffer C, et al. Among authors: Rathelot P. Eur J Med Chem. 2015 Mar 6;92:282-94. doi: 10.1016/j.ejmech.2014.12.056. Epub 2014 Dec 31. Eur J Med Chem. 2015. PMID: 25559208
Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series.
Kieffer C, Cohen A, Verhaeghe P, Paloque L, Hutter S, Castera-Ducros C, Laget M, Rault S, Valentin A, Rathelot P, Azas N, Vanelle P. Kieffer C, et al. Among authors: Rathelot P. Bioorg Med Chem. 2015 May 15;23(10):2377-86. doi: 10.1016/j.bmc.2015.03.064. Epub 2015 Mar 31. Bioorg Med Chem. 2015. PMID: 25846065
Discovery of new hit-molecules targeting Plasmodium falciparum through a global SAR study of the 4-substituted-2-trichloromethylquinazoline antiplasmodial scaffold.
Desroches J, Kieffer C, Primas N, Hutter S, Gellis A, El-Kashef H, Rathelot P, Verhaeghe P, Azas N, Vanelle P. Desroches J, et al. Among authors: Rathelot P. Eur J Med Chem. 2017 Jan 5;125:68-86. doi: 10.1016/j.ejmech.2016.09.029. Epub 2016 Sep 10. Eur J Med Chem. 2017. PMID: 27654395
Efficacy and toxicity of factor Xa inhibitors.
Bondarenko M, Curti C, Montana M, Rathelot P, Vanelle P. Bondarenko M, et al. Among authors: Rathelot P. J Pharm Pharm Sci. 2013;16(1):74-88. doi: 10.18433/j33p49. J Pharm Pharm Sci. 2013. PMID: 23683607 Free article. Review.
Safety review: squalene and thimerosal in vaccines.
Montana M, Verhaeghe P, Ducros C, Terme T, Vanelle P, Rathelot P. Montana M, et al. Among authors: Rathelot P. Therapie. 2010 Nov-Dec;65(6):533-41. doi: 10.2515/therapie/2010069. Epub 2010 Dec 23. Therapie. 2010. PMID: 21176760 Review.
33 results
Jump to page
Feedback